With its vast experience in medical and pharmaceutical research and management’s many years of entrepreneurial success in the natural health product industry, Mondias is well-positioned for future growth.
|Last Trade (size)||- (-)||Open||-|
|Change||- - -||Prev. Close||-|
|Day's Range||- - -||52-wk Range||- - -|
|Bid (size)||- (-)||Ask (size)||- (-)|
|Last Trade Time||-|
A total of 26,250,000 common shares issued to Mondias shareholders are escrowed pursuant to a TSX Venture Exchange Tier 2 value security escrow agreement.